Skin Microbiome Variation: Indicator or Risk Factor for Squamous Cell Carcinoma?
The skin microbiome may serve as biomarker for skin cancer progression.
Skin Cancer
Immune Checkpoint Inhibitors and Adverse Events in Older Patients With Melanoma
Researchers sought to investigate the connection between immune checkpoint inhibitors (ICIs) and immune- and autoimmune-related adverse events in older patients diagnosed with melanoma.
Ban of Indoor Tanning Beds Would Reduce Cancers, Cut Costs
The intervention would yield a net monetary benefit of £10.6 million and a net health benefit of 530 QALYs, researchers found.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
White Patients May Be Overdiagnosed With Melanoma
More than half of melanoma cases diagnosed among White patients in 2014 may represent cases of overdiagnosis, a study suggests.
Combo Appears Effective After Anti-PD-1 Failure in Advanced Melanoma
Ipilimumab plus nivolumab demonstrated efficacy in a phase 2 trial of patients with advanced melanoma who failed prior anti-PD-1 therapy.
Risks of Nonkeratinocyte Skin Cancers Higher in Solid Organ Transplant Recipients
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
Primary Care-Based Screening Ups Thin Melanoma Detection
The incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
Eponyms in Oncology: Virchow’s Node
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
Study Supports Reclassification of Cutaneous Squamous Cell Carcinoma
Patients in the very high risk group had a significantly higher risk of recurrence, metastasis, and death.
- Loading...
Loading...
Next post in NCCN 2022
Loading... 
Loading...